
|Articles|May 31, 2020
ASCRS 2020: Evolution of an administration technique for DEXYCU
Author(s)Alex Delaney-Gesing
Advertisement
Ophthalmology Times' David Hutton speaks with Michael Saidel, MD, a cornea and cataract specialist, on his presentation regarding "Evolution of an administration technique for DEXYCU (dexamethasone intraocular suspension) 9%" during the 2020 ASCRS virtual meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages
2
Dry Eye Awareness Month: building a strong optometry-ophthalmology co-management model
3
FDA grants priority review to Satralizumab sBLA for thyroid eye disease
4
REGENXBIO doses first patient in NAAVIGATE, phase 2b/3 sura-vec trial for diabetic retinopathy
5
























